Zage, P. E., Sirisaengtaksin, N., Liu, Y., Gireud, M., Brown, B. S., Palla, S., . . . Bean, A. J. (2012). UBE4B Levels Are Correlated with Clinical Outcomes in Neuroblastoma Patients and with Altered Neuroblastoma Cell Proliferation and Sensitivity to EGFR Inhibitors.
Chicago Style CitationZage, Peter E., Natalie Sirisaengtaksin, Yin Liu, Monica Gireud, Brandon S. Brown, Shana Palla, Kristen N. Richards, Dennis P.M Hughes, i Andrew J. Bean. UBE4B Levels Are Correlated With Clinical Outcomes in Neuroblastoma Patients and With Altered Neuroblastoma Cell Proliferation and Sensitivity to EGFR Inhibitors. 2012.
Cita MLAZage, Peter E., et al. UBE4B Levels Are Correlated With Clinical Outcomes in Neuroblastoma Patients and With Altered Neuroblastoma Cell Proliferation and Sensitivity to EGFR Inhibitors. 2012.